Does Southeast Asia have a growing role in vaccine development?
Seoul will trade gatherings at its famous royal palaces for meetings at two key clinical trial events to be hosted…
All articles by Robert Barrie
Robert Barrie
Robert Barrie is a trainee reporter for Medical Device Network, covering developments in the healthcare sector. Coming from a scientific and medical background, Robert has reported across various topics with expertise in neuroscience, genetics, and epidemiology. Previously, he worked on a freelance basis with New Scientist.
-
-
Tivic hits enrolment target for vagus nerve stimulation trial
Tivic Health has completed enrolment in a study being conducted to finetune its non-invasive vagus nerve stimulation (VNS) device that…
-
Xeltis wins FDA breakthrough status, enrols first patient in pivotal trial
Xeltis has hit two milestones for its vascular access conduit, with one coming in the regulatory arena and the other…
-
J&J MedTech wins IDE for Ottava to greenlight trials for surgical robot
After years of teasing an entry into the surgical robotics space, Johnson & Johnson (J&J) MedTech has completed a major…
-
Inflammatix begins trial evaluating mRNA test for patient infection status
Not long after netting $57m in financing, Inflammatix has kick started a clinical trial evaluating its technology for the management…
-
RAPT Therapeutics shares tumble by 48% after zelnecirnon programme cull
RAPT Therapeutics has called it quits on a clinical programme evaluating zelnecirnon (RPT193) in inflammatory disorders following feedback with the…
-
Hurricane Helene delays Spectral Medical’s confirmatory trial enrolment
Spectral Medical will have to wait to submit an application to the US Food and Drug Administration (FDA) for its…
-
Penumbra reveals positive data for algorithm-assisted thrombectomy tech
Penumbra has posted positive data for its computer-assisted vacuum thrombectomy (CAVT) technology aimed at treating patients with intermediate-risk pulmonary embolism…
-
Abbott touts long-term efficacy for dissolvable Esprit BTK stent
Abbott has unveiled positive long-term data for its Esprit below-the-knee (BTK) stent in treating the most severe form of peripheral…
-
Onward raises $54m to continue neuromodulation trials
Onward Medical has raised $54m (€50m) via a bookbuild offering, with proceeds going towards ongoing clinical studies and an expected…